Benefits of the Therapy With Abexol in Patients With Non-Alcoholic Fatty Liver Disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of diseases ranging from steatosis to steatohepatitis and cirrhosis. Given the increasing incidence of NAFLD and the long-term consequences of this disease, it is important to identify the risk factors and therapeutic measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez-Travieso, Julio Cesar, Rodriguez-Perez, Ivan, Ruenes-Domech, Caridad, lIlnait-Ferrer, Jose, Fernandez-Dorta, Lilia, Mendoza-Castano, Sarahi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188363/
https://www.ncbi.nlm.nih.gov/pubmed/32362966
http://dx.doi.org/10.14740/gr1273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188363/
https://www.ncbi.nlm.nih.gov/pubmed/32362966
http://dx.doi.org/10.14740/gr1273

Ejemplares similares